Related Experiment Videos
CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor.
1Department of Microbiology and Immunology, SUNY Health Science Center, Syracuse, NY 13210, USA. barkere@vax.cs.hscsyr.edu barkere@vax.cs.hscsyr.edu
The Journal of Infectious Diseases
|April 1, 1999
Summary
CD8+ cells control human immunodeficiency virus (HIV) replication through a non-damaging mechanism involving CD8+ cell antiviral factor (CAF). This factor suppresses viral transcription, crucial for preventing HIV disease progression.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Human immunodeficiency virus (HIV)-infected individuals exhibit CD8+ T cell responses that control viral replication.
- This control can be cytotoxic (cell destruction) or noncytotoxic, preserving infected cell function.
Purpose of the Study:
- To identify and characterize the soluble factor mediating the noncytotoxic CD8+ cell antiviral response against HIV.
- To elucidate the mechanism by which this factor suppresses HIV replication.
Main Methods:
- The study identified a novel soluble factor, CD8+ cell antiviral factor (CAF).
- CAF's mechanism of action was investigated, focusing on its effect on viral transcription and interaction with HIV regulatory elements.
Main Results:
- CAF suppresses HIV replication at the transcriptional level by interfering with Tat and host factors binding to HIV long terminal repeats.
- CAF demonstrates broad activity against diverse HIV isolates, including both syncytium-inducing and non-syncytium-inducing strains.
- The production of CAF by CD8+ cells is critical for controlling HIV replication and preventing disease progression.
Conclusions:
- CD8+ cell antiviral factor (CAF) is a key mediator of noncytotoxic control of HIV replication.
- CAF's broad-spectrum antiviral activity and its role in preventing disease progression highlight its therapeutic potential.